STIGALL L. JEREMY 4
4 · ClearPoint Neuro, Inc. · Filed Mar 14, 2025
Insider Transaction Report
Form 4
STIGALL L. JEREMY
Chief Business Officer
Transactions
- Tax Payment
Common Stock
2025-03-12$13.18/sh−5,545$73,083→ 74,308 total - Exercise/Conversion
Restricted Stock Units
2025-03-12−15,497→ 61,990 total→ Common Stock (15,497 underlying) - Exercise/Conversion
Common Stock
2025-03-12+15,497→ 79,853 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
- [F2]Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.